Chemours Sees Q3 Sales $1.511B-$1.591B vs $1.601B Est

Benzinga Newsdesk www.benzinga.com Positive 76.5%

Neg 0% Neu 0% Pos 76.5%

Chemours (NYSE:CC) sees Q3 sales of $1.511 billion-$1.591 billion vs $1.601 billion analyst estimate.

Comments

No comments yet. Be the first!